FDA Label for Rivastigmine
View Indications, Usage & Precautions
Rivastigmine Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
Rx only
NDC 70771-1949-7
Rivastigmine
Transdermal System
Each System Delivers 4.6 mg/24 hours
For Transdermal Use Only.
Contains 30 systems
Rx only
NDC 70771-1950-7
Rivastigmine
Transdermal System
Each System Delivers 9.5 mg/24 hours
For Transdermal Use Only.
Contains 30 systems
Rx only
NDC 70771-1951-7
Rivastigmine
Transdermal System
Each System Delivers 13.3 mg/24 hours
For Transdermal Use Only.
Contains 30 systems
* Please review the disclaimer below.
